Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
2019 · The Lancet · 2,820 citations
https://doi.org/10.1016/s0140-6736(19)31149-3
A
Aldo Prado
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
58
Papers
5.1K
Citations
16
h-index
21
i10-index
Aldo Prado is an academic researcher from Woodhull Medical and Mental Health Center. The author has contributed to research in topics: Cardiovascular Function and Risk Factors & Cardiac Valve Diseases and Treatments & Cardiac Imaging and Diagnostics. The author has an h-index of 16, co-authored 50 publications.
ORCID: 0000-0002-6057-700XPapers by this author
worksDulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
2019 · The Lancet · 600 citations
https://doi.org/10.1016/s0140-6736(19)31150-x
Similarities and Differences in Left Ventricular Size and Function among Races and Nationalities: Results of the World Alliance Societies of Echocardiography Normal Values Study
2019 · Journal of the American Society of Echocardiography · 179 citations
https://doi.org/10.1016/j.echo.2019.08.012
Global Variations in Heart Failure Etiology, Management, and Outcomes
2023 · JAMA · 136 citations
https://doi.org/10.1001/jama.2023.5942
Massive Left Atrial Calcification in Late Rheumatic Heart Disease
2022 · CASE · 1 citations
https://doi.org/10.1016/j.case.2022.02.006
SEX-SPECIFIC DIFFERENCES IN LEFT VENTRICULAR WALL THICKNESS AND MASS IN PATIENTS WITH TRANSTHYRETIN AND LIGHT CHAIN AMYLOIDOSIS
2025 · Journal of the American College of Cardiology · 0 citations
https://doi.org/10.1016/s0735-1097(25)01720-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat